Voon H Ong

5.6k total citations · 1 hit paper
103 papers, 3.0k citations indexed

About

Voon H Ong is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Voon H Ong has authored 103 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 89 papers in Pathology and Forensic Medicine, 33 papers in Pulmonary and Respiratory Medicine and 27 papers in Immunology. Recurrent topics in Voon H Ong's work include Systemic Sclerosis and Related Diseases (88 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (27 papers) and Inflammatory Myopathies and Dermatomyositis (26 papers). Voon H Ong is often cited by papers focused on Systemic Sclerosis and Related Diseases (88 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (27 papers) and Inflammatory Myopathies and Dermatomyositis (26 papers). Voon H Ong collaborates with scholars based in United Kingdom, Italy and United States. Voon H Ong's co-authors include Christopher P. Denton, Svetlana I. Nihtyanova, Pia Moinzadeh, Shiwen Xu, Athol U. Wells, David Abraham, David Abraham, Benjamin Schreiber, Carol M. Black and Emma Derrett‐Smith and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Voon H Ong

92 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prediction of Pulmonary Complications and Long‐Term Survival in Systemic Sclerosis

2014 325 citations Svetlana I. Nihtyanova, Voon H Ong et al. Arthritis & Rheumatology profile →

Peers

Voon H Ong

PFM

PRM

IMMUN

EPIDE

DERMA

Otylia Kowal‐Bielecka Poland

Silvia Bellando-Randone Italy

Patrícia Carreira Spain

Robyn T. Domsic United States

Jessica Gordon United States

K.P. Tiev France

Dimitrios Daoussis Greece

Giuseppina Farina United States

Mike Oliver Becker Switzerland

Bashar Kahaleh United States

Otylia Kowal‐Bielecka Poland

Voon H Ong

2.0k ×0.9

PFM

1.1k ×1.0

PRM

840 ×1.0

IMMUN

541 ×0.7

EPIDE

721 ×0.9

DERMA

Citations per year, relative to Voon H Ong Voon H Ong (= 1×) peers Otylia Kowal‐Bielecka

Countries citing papers authored by Voon H Ong

Since Specialization

Citations

This map shows the geographic impact of Voon H Ong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Voon H Ong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Voon H Ong more than expected).

Fields of papers citing papers by Voon H Ong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Voon H Ong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Voon H Ong. The network helps show where Voon H Ong may publish in the future.

Co-authorship network of co-authors of Voon H Ong

This figure shows the co-authorship network connecting the top 25 collaborators of Voon H Ong. A scholar is included among the top collaborators of Voon H Ong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Voon H Ong. Voon H Ong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ong, Voon H, et al.. (2025). Impact of immunosuppression on development and outcome of systemic sclerosis-associated pulmonary arterial hypertension. Clinical and Experimental Rheumatology. 43(8). 1492–1498. 1 indexed citations

Clark, Kristina E N, Shiwen Xu, Moustafa Attar, et al.. (2025). Characterization of a pathogenic nonmigratory fibroblast population in systemic sclerosis skin. JCI Insight. 10(10).

Denton, Christopher P., et al.. (2025). Impact of hand function impairment on daily life of patients with systemic sclerosis: a qualitative study. Lara D. Veeken. 65(1).

Ong, Voon H, Christopher P. Denton, Wouter Foppen, et al.. (2025). Hand function impairment in Systemic sclerosis: Outcomes, Mechanisms and Experience (HANDSOME) – a longitudinal observational multicentre study protocol. BMJ Open. 15(3). e095283–e095283. 1 indexed citations

Tam, Angela, Korsa Khan, Shiwen Xu, et al.. (2025). Critical Role for Transglutaminase 2 in Scleroderma Skin Fibrosis and in the Development of Dermal Sclerosis in a Mouse Model of Scleroderma. Arthritis & Rheumatology. 77(7). 914–928.

Nihtyanova, Svetlana I., Athol U. Wells, Christopher P. Denton, et al.. (2025). Tocilizumab and rituximab for systemic sclerosis interstitial lung disease: a real-world cohort analysis. Lara D. Veeken. 64(SI). SI184–SI189. 2 indexed citations

Spierings, Julia, Paco M J Welsing, Francesco Del Galdo, et al.. (2024). Self-reported skin severity and quality of life in systemic sclerosis: multicentre validation of PASTUL. Lara D. Veeken. 64(5). 2802–2809.

Ong, Voon H, et al.. (2024). Recent developments in connective tissue disease associated pulmonary arterial hypertension. SHILAP Revista de lepidopterología. 16. 100513–100513.

Clark, Kristina E N, et al.. (2023). Skin biopsy analysis of concurrent keloidal morphoea and systemic sclerosis confirms overlapping pathogenic pathways. Clinical and Experimental Rheumatology. 41(8). 1644–1651.

10.

Ong, Voon H, et al.. (2023). A Phenome-Wide Association Study of Drugs and Comorbidities Associated With Gastrointestinal Dysfunction in Systemic Sclerosis. The Journal of Rheumatology. 50(7). 907–915. 4 indexed citations

11.

Spierings, Julia, Voon H Ong, & Christopher P. Denton. (2022). Three Cases of Systemic Sclerosis Within One Family With Different Antibodies and Clinical Features. The Journal of Rheumatology. 49(5). 544–546. 1 indexed citations

12.

Spierings, Julia, Svetlana I. Nihtyanova, Emma Derrett‐Smith, et al.. (2021). Outcomes linked to eligibility for stem cell transplantation trials in diffuse cutaneous systemic sclerosis. Lara D. Veeken. 61(5). 1948–1956. 7 indexed citations

13.

Campochiaro, Corrado, et al.. (2020). High proton pump inhibitor exposure increases risk of calcinosis in systemic sclerosis. Lara D. Veeken. 60(2). 849–854. 10 indexed citations

14.

Stock, Carmel, Rachel K. Hoyles, Cécile Daccord, et al.. (2020). Serum markers of pulmonary epithelial damage in systemic sclerosis‐associated interstitial lung disease and disease progression. Respirology. 26(5). 461–468. 35 indexed citations

15.

Taher, Taher E., Jonas Byström, Voon H Ong, et al.. (2017). Intracellular B Lymphocyte Signalling and the Regulation of Humoral Immunity and Autoimmunity. Clinical Reviews in Allergy & Immunology. 53(2). 237–264. 39 indexed citations

16.

Hansi, Navjyot, Nora Thoua, Maresa Carulli, et al.. (2015). Consensus best practice pathway of the UK scleroderma study group: gastrointestinal manifestations of systemic sclerosis.. PubMed. 32(6 Suppl 86). S–214. 57 indexed citations

17.

Khan, Korsa, Shiwen Xu, Svetlana I. Nihtyanova, et al.. (2012). Clinical and pathological significance of interleukin 6 overexpression in systemic sclerosis. Annals of the Rheumatic Diseases. 71(7). 1235–1242. 163 indexed citations

18.

Ong, Voon H, Shiwen Xu, Korsa Khan, et al.. (2008). Cross-talk between MCP-3 and TGFβ promotes fibroblast collagen biosynthesis. Experimental Cell Research. 315(2). 151–161. 28 indexed citations

19.

Denton, Christopher P., Bing Zheng, Shiwen Xu, et al.. (2003). Fibroblast-specific Expression of a Kinase-deficient Type II Transforming Growth Factor β (TGFβ) Receptor Leads to Paradoxical Activation of TGFβ Signaling Pathways with Fibrosis in Transgenic Mice. Journal of Biological Chemistry. 278(27). 25109–25119. 104 indexed citations

20.

Harrison, Beverley, et al.. (2002). THE PRESENCE OF PSORIASIS MODIFIES DISEASE EXPRESSION OVER TIME AMONGST PATIENTS NEWLY PRESENTING WITH INFLAMMATORY POLYARTHRITIS. Lara D. Veeken. 41. 4–5. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact